跳至主要内容
临床试验/NCT04912882
NCT04912882尚未招募不适用

Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of Circulating Tumor Cells

Fudan University0 个研究点目标入组 1,000 人开始时间: 2021年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,000
主要终点
Specificity

研究概览

简要总结

Detecting circulating tumor cells from I-IV stage colorectal cancer patients pre-and post-operatively. Analyzing the morphology and biomarkers of CTCs and builting prognosis predicting model based on the morphology and biomarkers of CTCs. Verifying the prognosis model by the survival data.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-80 years;
  • Histologically proven colorectal carcinoma (TNM stage I-IV)
  • R0 resection is possible according to preoperative evaluation
  • Written informed consent for participation in the trial.

排除标准

  • Primary tumor or metastases not able to be removed radically
  • Receiving any preoperative treatment (Including chemotherapy, radiotherapy and target therapy)
  • Have other malignant tumors meanwhile
  • Other previous malignancy within 5 years

结局指标

主要结局

Specificity

时间窗: 1 year

The specificity of predictive model based on the number and type of circulating tumor cell

Sensitivity

时间窗: 1 year

The sensitivity of the predictive based on the number and type of circulating tumor cell

次要结局

  • AUC(1 year)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Prognosis Predicting of CRC Patients Based on... | 临床试验